SCP2D1 (SCP2 sterol binding domain containing 1) is a cytosolic protein with emerging roles in cancer biology and spermatogenesis. As a cancer-testis (CT) gene, SCP2D1 expression is normally restricted to germline cells but becomes aberrantly activated in certain cancers, particularly colon cancer, where it is expressed in approximately 35% of patient samples 1. SCP2D1 expression can be induced through epigenetic modifications in colon cancer cells using DNA methyltransferase and histone deacetylase inhibitors, suggesting DNA methylation regulates its transcriptional silencing in somatic cells 2. In reproductive biology, SCP2D1 mRNA is preferentially enriched in higher-density stallion spermatozoa 3, suggesting a role in spermatogenesis and potential fertility-related functions. The gene's lipid metabolism associations emerged from evolutionary studies examining positive selection in dogs during domestication, where SCP2D1 was identified among metabolism-related candidate genes 4. Given its restricted normal expression pattern combined with aberrant activation in cancer, SCP2D1 represents a potential biomarker for early colon cancer detection and a therapeutic target. However, the specific biochemical mechanisms underlying its sterol-binding function and its precise role in both normal spermatogenesis and oncogenic processes require further investigation.